In 2023, we published another article about CRSP in Cell Biology Education – A Journal of Life Science Education. That article assesses the impact of shifting research modalities and their impacts on ...

Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients with solid tumors ...

The SNU BioTalk 2025 an International Conference, themed "Symphony of Cellular Signals in Metabolism and Immune Response," ...

The bit.bio team will be at Booth #851, present multiple poster ... cell visualisation in complex model systems," said Mark Kotter, Founder of bit.bio. "We are committed to relentlessly innovating ...

By sharing the stories of EDI champions in science, we hope to shed light on both the importance of diversity and the ...

Blueprint Medicines Corporation ( NASDAQ: BPMC) Q4 2024 Earnings Conference Call February 13, 2025 8:00 AM ET ...

THB335 Phase 1 data support advancement into Phase 2 clinical trial in chronic spontaneous urticaria (CSU)Company initiating process to leverage ...

Newsweek has contacted the original poster for comment via TikTok ... Cambridge University study in May 2016 in Cell Metabolism. Eleanor Raffan, a co-author of the study, said that "there is some ...

Vaccines for cancer may have seem like a pipe dream a few years ago, but with the great work of scientists and researchers we have made great strides towards cancer treatments. This new vaccine may be ...

The European Laboratory Research & Innovation Group (ELRIG) has announced the keynote speakers for Research & Innovation 2025 ...

Christopher Demos-Brown’s “The Cancellation of Lauren Fein," now on stage at Florida Studio Theatre, is a well-written, ...

Health systems are facing hurdles to implementing new and effective metastatic urothelial carcinoma (mUC) therapies into ...